Companies
C16 Biosciences
the New York pioneer whose Palmless platform makes yeast-fermented oils and fats, backed by Breakthrough Energy Ventures and with an FDA GRAS determination that opens the route to US food-industry integration alongside its cosmetic B2B sales.
- Country
- United States
FDA GRAS
ISO 22000
Coverage
| CN | EU | US | |
|---|---|---|---|
| specialty-fine-chem | ✓ | ✓ | ✓ |
Regulatorsfdaefsareach
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | $34 million total funding | greenqueen.com.hk |
| Capacity | 50,000-liter industrial-scale fermentation tanks | apnews.com · c16bio.com · cnbc.com |
| Certification | USDA BioPreferred certification for Torula oil | greenqueen.com.hk |
| Production site | single site industrial-scale facility | apnews.com |
| Headcount | approximately 16 to 34 employees medium confidence | getlatka.com |
| Revenue | estimated between $3.3 million and $15 million annually medium confidence | getlatka.com · prospeo.io |
Independent sources: apnews.com · cnbc.com · getlatka.com · greenqueen.com.hk · prospeo.io
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Biosynthetic palm fat | specialty-fine-chem | Medium | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.